AbbVie Inc./ US00287Y1091 /
2/3/2023 12:56:58 PM | Chg. -0.4600 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
132.5600EUR | -0.35% | 100 Turnover: 13,256 |
134.4200Bid Size: 90 | 134.7800Ask Size: 90 | 239.86 bill.EUR | - | - |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 6.48 USD | 137.36% |
EPS Diluted: | 6.45 USD | 137.13% |
Revenues per Share: | 31.77 USD | 22.49% |
Book Value per Share: | 8.73 USD | 17.67% |
Cash Flow per Share: | 12.88 USD | 29.29% |
Dividend per Share: | 5.31 USD | 9.71% |
Total | in mill. | |
Revenues: | 56,197.00 USD | 22.69% |
Net Income: | 11,542.00 USD | 150.04% |
Operating Cash Flow: | 22,777.00 USD | - |
Cash and Cash Equivalents: | 9,746.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 22.41 | 20.90 |
P/S Ratio: | 4.57 | 4.26 |
P/BV ratio: | 16.64 | 15.52 |
P/CF Ratio: | 11.28 | 10.51 |
PEG: | 0.16 | 0.15 |
Earnings Yield: | 4.46% | 4.79% |
Dividend Yield: | 3.66% | 3.92% |
Market Capitalization | ||
Market Capitalization: | 239.86 bill. EUR | 210.54 bill. EUR |
Free Float Market Cap.: | 202.49 bill. EUR | 177.73 bill. EUR |
Market Cap. / Employee: | 4.8 mill. EUR | 4.21 mill. EUR |
Shares Outstanding: | 1.77 bill. |
Profitability
Gross Profit Margin: | 100.00% |
EBIT Margin: | 31.89% |
Net Profit Margin: | 20.54% |
Return on Equity: | 74.77% |
Return on Assets: | 7.88% |
Financial Strength
Liquidity I / Cash Ratio: | 27.69% |
Liquidity II / Quick Ratio: | 56.04% |
Liquidity III / Current Ratio: | 79.35% |
Debt / Equity Ratio: | 849.27% |
Dynam. Debt / Equity Ratio: | 575.55% |
Efficiency
Employees: | 50,000 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 1,123,940.00 USD |
Net Income / Employee: | 230,840.00 USD |
Total Assets / Employee: | 2,930,580.00 USD |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | US GAAP |
Currency: | USD |